Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,982

Document Document Title
WO/2021/064189A2
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them hig...  
WO/2021/066435A1
The present invention relates to a compound for an organic electric element, an organic electric element using same, and an electronic device comprising the organic electric element. According to the present invention, an organic electri...  
WO/2021/060276A1
Provided, inter alia, is a fluorinating agent that can selectively produce a monofluorination product through preferential synthesis of the monofluorination product over a difluorination product, in a fluorination reaction in which a flu...  
WO/2021/047525A1
The present invention relates to the technical field of medicine, and provides a salt of a benzothiopyrone compound, and a preparation method therefor and an application thereof, in particular, a salt of 2-(4-(cyclohexylmethyl)piperazin-...  
WO/2021/049470A1
The purpose of the present invention is to provide a compound having excellent acid generation sensitivity. The present invention is a compound represented by general formula (A) below. (In the formula, R11 and R20 each independently r...  
WO/2021/039654A1
The present invention provides: an active-ray-sensitive or radiation-sensitive resin composition having a solid material concentration of 10% by mass or more, the active-ray-sensitive or radiation-sensitive resin composition comprising a...  
WO/2021/029158A1
The purpose of the present invention is to provide: a sulfonamide compound which has a high decomposition rate in response to near-ultraviolet rays and which generates a superacid bis-sulfonamide, and which is highly soluble in a resist ...  
WO/2021/023119A1
Provided is a co-crystal formed by flupentixol dihydrochloride and melitracen hydrochloride, wherein the molar ratio of flupentixol dihydrochloride and melitracen hydrochloride in the co-crystal is 1:1. The co-crystal has a good stabilit...  
WO/2021/026179A1
The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositio...  
WO/2021/020429A1
The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof which has the effect of antagonizing the LPA1 receptor.  
WO/2020/261021A1
Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high ener...  
WO/2020/218680A1
The present invention relates to a novel organic light emitting compound and an organic electroluminescent diode using same and, more specifically, to: a compound having excellent thermal stability, electrochemical stability, light emitt...  
WO/2020/216777A1
The present invention relates to a composition comprising a compound of formula (I) wherein X is selected from the group consisting of S, Se, P, PO, SO, NR1, CR1, CR1R1 or C0-2-alkyl; Z is selected from the group consisting of hydrogen, ...  
WO/2020/159019A1
The present invention relates to a novel organic light-emitting compound and an organic electroluminescent device using same and, more specifically, to a compound having excellent thermal stability, electrochemical stability, light-emitt...  
WO/2020/158870A1
The purpose in one embodiment of the present invention is to provide a therapeutic for Parkinson's disease, etc. A compound represented by formulas (1), (2), or (8) or a pharmacologically acceptable salt thereof can be used in the treatm...  
WO/2020/151623A1
The present invention pertains to the medical field and relates to a compound of formula (III), a stereoisomer or pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the compound, a ster...  
WO/2020/151621A1
The present invention belongs to the field of medicine, and specifically relates to a compound of formula (I), an isomer or a pharmaceutical salt thereof. This present invention more specifically relates to a compound, a stereoisomer the...  
WO/2020/153669A1
The present invention relates to a compound for an organic electric device, an organic electric device using same, and an electronic apparatus thereof. According to the present invention, high luminous efficiency, low driving voltage, an...  
WO/2020/145043A1
Provided are: a novel sulfonium salt which exhibits high photosensitivity to g rays or h rays; and a novel photoacid generator containing a sulfonium salt which exhibits high photosensitivity to g rays or h rays, high solubility in a sol...  
WO/2020/137921A1
The present invention provides an actinic light sensitive or radiation sensitive resin composition, a resist film, a pattern forming method, and an electronic device production method, wherein the actinic light sensitive or radiation sen...  
WO/2020/134138A1
The present disclosure relates to the technical field of luminescent materials, and relates in particular to an organic electroluminescent compound, a preparation method therefor and an organic electroluminescent device. In order to solv...  
WO/2020/109132A1
A radiation curable inkjet ink comprising a polymerizable compound and a photoinitiator, characterized in that the photoinitiator comprises a functional group selected from the group consisting of an aliphatic thio-ether and an aliphatic...  
WO/2020/086691A1
This current disclosure is directed to charge-transfer heptamethine dyes for NIR singlet oxygen generation, each such dye comprising a near-infrared (NIR) absorbing dye having heptamethine linkages orthogonally coupled to an optionally s...  
WO/2020/067118A1
A dialkyl peroxide including a thioxanthone group, characterized by being represented by general formula (1) (wherein R1, R2, R3, and R4 each independently represent a methyl or ethyl group; R5 represents a C1-6 alkyl group or a phenyl g...  
WO/2020/052774A1
The application provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DNA) inhibitors.  
WO/2020/053249A1
The present invention provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DMA) inhibitors.  
WO/2020/016389A1
Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitated methods for producing photoresist structures.  
WO/2020/004601A1
Provided are: an oxime ester compound useful as a photopolymerization initiator used in a polymerizable composition; and a photopolymerization initiator containing the oxime ester compound. This compound has a group represented by genera...  
WO/2019/226490A1
Provided is a compound of Formula (I), wherein the variable groups are defined herein.  
WO/2019/203491A1
The present specification provides a compound of formula 1 and an organic light emitting device comprising same.  
WO/2019/194136A1
Provided are a photosensitive composition having an excellent sensitivity, a cured film, a method for manufacturing a color filter, a color filter, a solid-state imaging element, and an image display device. The photosensitive compositio...  
WO/2019/182411A1
The present specification relates to a heterocyclic compound of chemical formula 1 and an organic light-emitting device comprising same.  
WO/2019/182360A1
Provided, according to the present invention, are a compound which may be applied to an electron transport layer of an organic light-emitting device, an organic light-emitting device using such compound and an organic EL display device c...  
WO/2019/172699A1
The present specification provides a compound represented by chemical formula 1 and an organic light emitting device comprising same.  
WO/2019/160079A1
Provided are a radical polymerization initiator having excellent sensitivity and solubility in water, a composition containing the same, a cured product of the composition, a production method for the cured product, and a compound. The...  
WO/2019/142880A1
A compound represented by formula (I) or a salt thereof. (In formula (I): Q1 represents an optionally substituted C6-10 aryl group; Q2 represents an optionally substituted C6-10 aryl group or an optionally substituted 5-10 membered heter...  
WO/2019/119141A1
The present application is directed to compounds of Formula (I): compounds of Formula (II): compounds of Formula (III): and compounds of Formula (IV): compositions comprising these compounds and their uses, for example as medicaments and...  
WO/2019/120099A1
The present invention relates to an organic mixture and the use thereof in an organic electronic device. The organic mixture comprises organic materials H1 and H2, wherein H1 is a compound as shown in the following general formula (1), a...  
WO/2019/094788A1
The present technology relates to compounds that inhibit human Ly6K and homologs thereof. Also disclosed are methods of using such compounds to: inhibit activity of a Ly6K protein in a cell; decrease migration, colony formation, and/or p...  
WO/2019/085758A1
Disclosed in the present invention are a ketone-containing compound and applications thereof in organic electroluminescent devices. The compound consists of ketone and spiroanthracenefluorene groups, has a very deep HOMO energy level and...  
WO/2019/063955A1
The present invention concerns the compounds of the following formula (I): (I) in which: - X represents an oxygen atom, a sulfur atom, a nitrogen atom or a CH radical, - The X--Y bond and Y are absent if X represents an oxygen or sulfur ...  
WO/2019/061299A1
Provided is a one-step amination reaction for producing an aminomethyl substituted heterocycloalkane, notably (tetrahydrofuran-2, 5-diyl) dimethanamine.  
WO/2019/039290A1
Provided are: an actinic ray-sensitive or radiation-sensitive resin composition that has excellent resolution, exposure latitude, and pattern shape properties; and a resist film, a pattern-forming method, a method for producing an electr...  
WO/2019/027263A1
The present application provides a heterocyclic compound represented by Chemical Formula 1, and an organic light-emitting element including same.  
WO/2019/022002A1
A compound represented by formula (I) or a salt thereof. (In formula (I), Q1 represents an (un)substituted C6-10 aryl group; Q2 represents an (un)substituted C1-6 alkyl group, an (un)substituted C6-10 aryl group, or a five- to ten-member...  
WO/2019/013542A1
The present specification relates to a heterocyclic compound represented by chemical formula 1 and an organic light emitting element comprising the same.  
WO/2019/008156A1
The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-1/PD-L1 protein/protein interaction. The compounds may be used in the treatment of cancer, infectious diseases and neurodegenerative di...  
WO/2019/004790A1
The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting element including same.  
WO/2019/001268A1
The present invention discloses a PEGylated thioxanthone photoinitiator and a photosensitive resin composition. The PEGylated thioxanthone compound is low in toxicity, environmentally friendly, and leaves little residue after curing as a...  
WO/2019/004612A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  

Matches 1 - 50 out of 2,982